Cultured AFB Antitubercular DST Rapid 16 Drugs Panel Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Rapid 16 Drugs Panel Test represents a breakthrough in tuberculosis diagnostics, providing comprehensive drug sensitivity profiling for Mycobacterium tuberculosis complex. This advanced test evaluates bacterial resistance to 16 different anti-tuberculosis medications, enabling physicians to create personalized treatment plans for patients with drug-resistant TB strains.
What This Test Measures and Detects
This sophisticated diagnostic panel assesses Mycobacterium tuberculosis complex sensitivity to a comprehensive range of anti-tuberculosis medications:
- First-line Drugs: Streptomycin, Isoniazid, Rifampicin, Ethambutol, Pyrazinamide
- Second-line Drugs: Clofazimine, Ethionamide, Capreomycin, Kanamycin, Amikacin
- Fluoroquinolones: Ofloxacin, Levofloxacin, Moxifloxacin
- Other Agents: PAS (Para-aminosalicylic acid), Cycloserine, Linezolid
Who Should Consider This Test
This comprehensive drug sensitivity testing is recommended for individuals experiencing:
- Persistent cough lasting more than 3 weeks
- Unexplained weight loss and night sweats
- Previous tuberculosis treatment failure
- Known exposure to drug-resistant TB strains
- Immunocompromised conditions increasing TB risk
- Healthcare workers with potential TB exposure
- Patients from regions with high drug-resistant TB prevalence
Benefits of Comprehensive Drug Sensitivity Testing
- Personalized Treatment: Enables physicians to select the most effective medications based on individual bacterial resistance patterns
- Reduced Treatment Duration: Identifies effective drugs early, potentially shortening treatment time
- Prevention of Drug Resistance: Helps avoid using ineffective medications that could promote further resistance
- Improved Outcomes: Significantly increases treatment success rates for drug-resistant tuberculosis
- Cost-Effective Care: Prevents unnecessary medication expenses and hospitalizations
Understanding Your Test Results
Your test results will provide detailed information about which anti-tuberculosis medications are effective against your specific Mycobacterium tuberculosis strain:
- Sensitive Results: Indicates the medication is effective and can be included in your treatment regimen
- Resistant Results: Shows the medication is ineffective and should be avoided in your treatment plan
- Intermediate Results: May require higher dosing or combination therapy approaches
Your physician will interpret these results in the context of your overall health status and develop a customized treatment strategy.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST Rapid 16 Drugs Panel Test | $626 USD | $876 USD |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Control of Your Tuberculosis Treatment
Don’t let drug-resistant tuberculosis compromise your health. Our comprehensive 16-drug panel provides the critical information needed to develop an effective, personalized treatment plan. With rapid turnaround times and advanced automated fluorescent technology, you can get the answers you need to fight tuberculosis effectively.
Ready to get started? Book your Cultured AFB Antitubercular DST Rapid 16 Drugs Panel Test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Our team is available to answer your questions and guide you through the testing process.
